Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $17,012 | 5 | 79.4% |
| Travel and Lodging | $3,093 | 6 | 14.4% |
| Food and Beverage | $1,333 | 13 | 6.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $12,927 | 10 | $0 (2019) |
| Mallinckrodt Hospital Products Inc. | $5,960 | 3 | $0 (2020) |
| Actelion Pharmaceuticals, Ltd | $2,301 | 9 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $249.26 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $5,960 | 3 | Mallinckrodt Hospital Products Inc. ($5,960) |
| 2019 | $12,855 | 8 | Mallinckrodt Enterprises LLC ($12,855) |
| 2018 | $72.31 | 2 | Mallinckrodt LLC ($72.31) |
| 2017 | $2,550 | 11 | Actelion Pharmaceuticals, Ltd ($2,301) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/28/2020 | Mallinckrodt Hospital Products Inc. | — | Consulting Fee | Cash or cash equivalent | $5,175.00 | General |
| 01/28/2020 | Mallinckrodt Hospital Products Inc. | — | Travel and Lodging | Cash or cash equivalent | $777.37 | General |
| 01/28/2020 | Mallinckrodt Hospital Products Inc. | — | Food and Beverage | Cash or cash equivalent | $7.35 | General |
| 10/29/2019 | Mallinckrodt Enterprises LLC | — | Food and Beverage | In-kind items and services | $107.51 | General |
| 07/02/2019 | Mallinckrodt Enterprises LLC | — | Consulting Fee | Cash or cash equivalent | $6,000.00 | General |
| 07/02/2019 | Mallinckrodt Enterprises LLC | — | Travel and Lodging | Cash or cash equivalent | $633.04 | General |
| 06/01/2019 | Mallinckrodt Enterprises LLC | — | Food and Beverage | In-kind items and services | $697.24 | General |
| 06/01/2019 | Mallinckrodt Enterprises LLC | — | Travel and Lodging | In-kind items and services | $389.94 | General |
| 02/05/2019 | Mallinckrodt Enterprises LLC | — | Food and Beverage | In-kind items and services | $29.16 | General |
| 01/02/2019 | Mallinckrodt Enterprises LLC | — | Consulting Fee | Cash or cash equivalent | $4,167.00 | General |
| 01/02/2019 | Mallinckrodt Enterprises LLC | — | Travel and Lodging | Cash or cash equivalent | $831.28 | General |
| 11/17/2018 | Mallinckrodt LLC | — | Food and Beverage | In-kind items and services | $23.82 | General |
| 11/16/2018 | Mallinckrodt LLC | — | Food and Beverage | In-kind items and services | $48.49 | General |
| 09/15/2017 | Actelion Pharmaceuticals, Ltd | ZAVESCA MIGLUSTAT (Drug) | Consulting Fee | Cash or cash equivalent | $140.68 | General |
| Category: GENETIC DISORDER | ||||||
| 08/21/2017 | Actelion Pharmaceuticals, Ltd | — | Consulting Fee | Cash or cash equivalent | $1,529.18 | General |
| 06/23/2017 | Actelion Pharmaceuticals, Ltd | — | Travel and Lodging | Cash or cash equivalent | $331.00 | General |
| 06/20/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug) | Food and Beverage | In-kind items and services | $124.65 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/18/2017 | Actelion Pharmaceuticals, Ltd | ZAVESCA MIGLUSTAT (Drug) | Food and Beverage | In-kind items and services | $43.30 | General |
| Category: GENETIC DISORDER | ||||||
| 05/18/2017 | Actelion Pharmaceuticals, Ltd | ZAVESCA MIGLUSTAT (Drug) | Food and Beverage | In-kind items and services | $8.88 | General |
| Category: GENETIC DISORDER | ||||||
| 05/17/2017 | Actelion Pharmaceuticals, Ltd | ZAVESCA MIGLUSTAT (Drug) | Travel and Lodging | Cash or cash equivalent | $129.89 | General |
| Category: GENETIC DISORDER | ||||||
| 05/17/2017 | Actelion Pharmaceuticals, Ltd | ZAVESCA MIGLUSTAT (Drug) | Food and Beverage | In-kind items and services | $65.50 | General |
| Category: GENETIC DISORDER | ||||||
| 05/17/2017 | Actelion Pharmaceuticals, Ltd | ZAVESCA MIGLUSTAT (Drug) | Food and Beverage | In-kind items and services | $43.30 | General |
| Category: GENETIC DISORDER | ||||||
| 05/17/2017 | Actelion Pharmaceuticals, Ltd | ZAVESCA MIGLUSTAT (Drug) | Food and Beverage | In-kind items and services | $8.88 | General |
| Category: GENETIC DISORDER | ||||||
| 03/29/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug) | Food and Beverage | In-kind items and services | $124.61 | General |
| Category: ENDOCRINOLOGY | ||||||
About Dr. Daniel Ory, MD
Dr. Daniel Ory, MD is a Cardiovascular Disease healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164448478.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Ory, MD has received a total of $21,437 in payments from pharmaceutical and medical device companies, with $5,960 received in 2020. These payments were reported across 24 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($17,012).
Practice Information
- Specialty Cardiovascular Disease
- Location Saint Louis, MO
- Active Since 07/14/2006
- Last Updated 01/24/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1164448478
Products in Payments
- ZAVESCA MIGLUSTAT (Drug) $440.43
- JANUVIA (Drug) $249.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Saint Louis
Dr. Jasvindar Singh, Md, MD
Cardiovascular Disease — Payments: $883,337
Dr. Harvey Serota, M.d, M.D
Cardiovascular Disease — Payments: $730,638
Dr. Daniel Kelly, Md, MD
Cardiovascular Disease — Payments: $538,763
Dr. Alan Zajarias, Md, MD
Cardiovascular Disease — Payments: $195,866
Dr. George Kichura, M.d, M.D
Cardiovascular Disease — Payments: $194,189
Dr. Anish Thomas, M.d, M.D
Cardiovascular Disease — Payments: $189,906